Diabetes 54:1692-1697, 2005
© 2005 by the American Diabetes Association, Inc.
Insulin-Stimulated Phosphorylation of the Akt Substrate AS160 Is Impaired in Skeletal Muscle of Type 2 Diabetic Subjects
Håkan K.R. Karlsson1,
Juleen R. Zierath1,
Susan Kane2,
Anna Krook3,
Gustav E. Lienhard2, and
Harriet Wallberg-Henriksson3
1 Department of Surgical Sciences, Integrative Physiology Section, Karolinska Institutet, Stockholm, Sweden
2 Department of Biochemistry, Dartmouth Medical School, Hanover, New Hampshire
3 Department of Physiology and Pharmacology, Integrative Physiology Section, Karolinska Institutet, Stockholm, Sweden
AS160 is a newly described substrate for the protein kinase Akt that links insulin signaling and GLUT4 trafficking. In this study, we determined the expression of and in vivo insulin action on AS160 in human skeletal muscle. In addition, we compared the effect of physiological hyperinsulinemia on AS160 phosphorylation in 10 lean–to–moderately obese type 2 diabetic and 9 healthy subjects. Insulin infusion increased the phosphorylation of several proteins reacting with a phospho-Akt substrate antibody. We focused on AS160, as this Akt substrate has been linked to glucose transport. A 160-kDa phosphorylated protein was identified as AS160 by immunoblot analysis with an AS160-specific antibody. Physiological hyperinsulinemia increased AS160 phosphorylation 2.9-fold in skeletal muscle of control subjects (P < 0.001). Insulin-stimulated AS160 phosphorylation was reduced 39% (P < 0.05) in type 2 diabetic patients. AS160 protein expression was similar in type 2 diabetic and control subjects. Impaired AS160 phosphorylation was related to aberrant Akt signaling; insulin action on Akt Ser473 phosphorylation was not significantly reduced in type 2 diabetic compared with control subjects, whereas Thr308 phosphorylation was impaired 51% (P < 0.05). In conclusion, physiological hyperinsulinemia increases AS160 phosphorylation in human skeletal muscle. Moreover, defects in insulin action on AS160 may impair GLUT4 trafficking in type 2 diabetes.
Address correspondencereprint requests to Juleen R. Zierath, PhD, Karolinska Institutet, Department of Surgical Sciences, Integrative Physiology Section, S-171 77, Stockholm, Sweden. E-mail: juleen.zierath{at}fyfa.ki.se
Abbreviations:
GAP, GTPase-activating protein; GSK-3 , glycogen synthase kinase 3 ; IRS, insulin receptor substrate 1; mTOR, mammalian target of rapamycin; PAS, anti-phospho-(Ser/Thr) Akt substrate; PI, phosphatidylinositol; TBST, Tris-buffered saline with 0.02% Tween

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. O. Chavez, J. C. Lopez-Alvarenga, M. E. Tejero, C. Triplitt, R. A. Bastarrachea, A. Sriwijitkamol, P. Tantiwong, V. S. Voruganti, N. Musi, A. G. Comuzzie, et al.
Physiological and Molecular Determinants of Insulin Action in the Baboon
Diabetes,
April 1, 2008;
57(4):
899 - 908.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. E. Friedman, J. P. Kirwan, M. Jing, L. Presley, and P. M. Catalano
Increased Skeletal Muscle Tumor Necrosis Factor-{alpha} and Impaired Insulin Signaling Persist in Obese Women With Gestational Diabetes Mellitus 1 Year Postpartum
Diabetes,
March 1, 2008;
57(3):
606 - 613.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Hojlund, D. Glintborg, N. R. Andersen, J. B. Birk, J. T. Treebak, C. Frosig, H. Beck-Nielsen, and J. F.P. Wojtaszewski
Impaired Insulin-Stimulated Phosphorylation of Akt and AS160 in Skeletal Muscle of Women With Polycystic Ovary Syndrome Is Reversed by Pioglitazone Treatment
Diabetes,
February 1, 2008;
57(2):
357 - 366.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. F. Kramer, E. B. Taylor, C. A. Witczak, N. Fujii, M. F. Hirshman, and L. J. Goodyear
Calmodulin-Binding Domain of AS160 Regulates Contraction- but Not Insulin-Stimulated Glucose Uptake in Skeletal Muscle
Diabetes,
December 1, 2007;
56(12):
2854 - 2862.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Alkhateeb, A. Chabowski, J. F. C. Glatz, J. F. P. Luiken, and A. Bonen
Two phases of palmitate-induced insulin resistance in skeletal muscle: impaired GLUT4 translocation is followed by a reduced GLUT4 intrinsic activity
Am J Physiol Endocrinol Metab,
September 1, 2007;
293(3):
E783 - E793.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. F. Howlett, K. Sakamoto, A. Garnham, D. Cameron-Smith, and M. Hargreaves
Resistance Exercise and Insulin Regulate AS160 and Interaction With 14-3-3 in Human Skeletal Muscle
Diabetes,
June 1, 2007;
56(6):
1608 - 1614.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. D. Wadley, N. Konstantopoulos, L. Macaulay, K. F. Howlett, A. Garnham, M. Hargreaves, and D. Cameron-Smith
Increased insulin-stimulated Akt pSer473 and cytosolic SHP2 protein abundance in human skeletal muscle following acute exercise and short-term training
J Appl Physiol,
April 1, 2007;
102(4):
1624 - 1631.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. B. Arias, J. Kim, K. Funai, and G. D. Cartee
Prior exercise increases phosphorylation of Akt substrate of 160 kDa (AS160) in rat skeletal muscle
Am J Physiol Endocrinol Metab,
April 1, 2007;
292(4):
E1191 - E1200.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. T. Treebak, J. B. Birk, A. J. Rose, B. Kiens, E. A. Richter, and J. F. P. Wojtaszewski
AS160 phosphorylation is associated with activation of {alpha}2beta2{gamma}1- but not {alpha}2beta2{gamma}3-AMPK trimeric complex in skeletal muscle during exercise in humans
Am J Physiol Endocrinol Metab,
March 1, 2007;
292(3):
E715 - E722.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. S.L. Thong, P. J. Bilan, and A. Klip
The Rab GTPase-Activating Protein AS160 Integrates Akt, Protein Kinase C, and AMP-Activated Protein Kinase Signals Regulating GLUT4 Traffic
Diabetes,
February 1, 2007;
56(2):
414 - 423.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Sun and P. Ernsberger
Marked Insulin Resistance in Obese Spontaneously Hypertensive Rat Adipocytes Is Ameliorated by in Vivo but Not in Vitro Treatment with Moxonidine
J. Pharmacol. Exp. Ther.,
February 1, 2007;
320(2):
845 - 852.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. B.M. Nascimento, M. Fodor, G. C.M. van der Zon, I. M. Jazet, A. E. Meinders, P. J. Voshol, R. Vlasblom, B. Baan, J. Eckel, J. A. Maassen, et al.
Insulin-Mediated Phosphorylation of the Proline-Rich Akt Substrate PRAS40 Is Impaired in Insulin Target Tissues of High-Fat Diet-Fed Rats
Diabetes,
December 1, 2006;
55(12):
3221 - 3228.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. R. Peck, S. Ye, V. Pham, R. N. Fernando, S. L. Macaulay, S. Y. Chai, and A. L. Albiston
Interaction of the Akt Substrate, AS160, with the Glucose Transporter 4 Vesicle Marker Protein, Insulin-Regulated Aminopeptidase
Mol. Endocrinol.,
October 1, 2006;
20(10):
2576 - 2583.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. T. Treebak, S. Glund, A. Deshmukh, D. K. Klein, Y. C. Long, T. E. Jensen, S. B. Jorgensen, B. Viollet, L. Andersson, D. Neumann, et al.
AMPK-Mediated AS160 Phosphorylation in Skeletal Muscle Is Dependent on AMPK Catalytic and Regulatory Subunits.
Diabetes,
July 1, 2006;
55(7):
2051 - 2058.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. F. Kramer, C. A. Witczak, N. Fujii, N. Jessen, E. B. Taylor, D. E. Arnolds, K. Sakamoto, M. F. Hirshman, and L. J. Goodyear
Distinct Signals Regulate AS160 Phosphorylation in Response to Insulin, AICAR, and Contraction in Mouse Skeletal Muscle.
Diabetes,
July 1, 2006;
55(7):
2067 - 2076.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Deshmukh, V. G. Coffey, Z. Zhong, A. V. Chibalin, J. A. Hawley, and J. R. Zierath
Exercise-Induced Phosphorylation of the Novel Akt Substrates AS160 and Filamin A in Human Skeletal Muscle
Diabetes,
June 1, 2006;
55(6):
1776 - 1782.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. K.R. Karlsson, M. Ahlsen, J. R. Zierath, H. Wallberg-Henriksson, and H. A. Koistinen
Insulin signaling and glucose transport in skeletal muscle from first-degree relatives of type 2 diabetic patients.
Diabetes,
May 1, 2006;
55(5):
1283 - 1288.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Hers, M. Wherlock, Y. Homma, H. Yagisawa, and J. M. Tavare
Identification of p122RhoGAP (Deleted in Liver Cancer-1) Serine 322 as a Substrate for Protein Kinase B and Ribosomal S6 Kinase in Insulin-stimulated Cells
J. Biol. Chem.,
February 24, 2006;
281(8):
4762 - 4770.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Plomgaard, K. Bouzakri, R. Krogh-Madsen, B. Mittendorfer, J. R. Zierath, and B. K. Pedersen
Tumor Necrosis Factor-{alpha} Induces Skeletal Muscle Insulin Resistance in Healthy Human Subjects via Inhibition of Akt Substrate 160 Phosphorylation
Diabetes,
October 1, 2005;
54(10):
2939 - 2945.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. S. L. Thong, C. B. Dugani, and A. Klip
Turning Signals On and Off: GLUT4 Traffic in the Insulin-Signaling Highway
Physiology,
August 1, 2005;
20(4):
271 - 284.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 by the American Diabetes Association.
|
|
| |
|